Biotechnology company developing personalized cancer immunotherapies by combining AI-driven selection of immune agonists with an injectable mesoporous silica biomaterial scaffold that delivers therapeutic agents locally within the tumor microenvironment
Biotechnology company developing personalized cancer immunotherapies by combining AI-driven selection of immune agonists with an injectable mesoporous silica biomaterial scaffold that delivers therapeutic agents locally within the tumor microenvironment.